An Additional Visceral Impression on Spleen – A Rare Anatomical Scenario
Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 11
Abstract
An accessory spleen is a small mass of splenic tissue, found apart from main body. An unexpectedly rare location of accessory spleen in phrenicocolic ligament was encountered during the course of preclinical cadaveric dissection programme. The accessory spleen also created an oval impression measuring 2.5x2 cm on the visceral surface of the spleen. Precise knowledge of such anatomical variants is relevant to Radiologists and Surgeons in their clinical practice.
Authors and Affiliations
SHWETA KUMARI, PRABHAT GOEL, SHIKHA SINGH, VANDANA MEHTA, RAJESH KUMAR SURI
MRI Study on Spinal Canal Morphometry: An Indian Study
Introduction: A large proportion of adults suffer from neck pain at some points of their life and show altered ranges of spinal canal morphometry in various studies. The differences in values are also seen due to genetic...
Jategaonkar’s Triple-Jerk Technique: A Safety Augmenting Method for Laparoscopic Suprapubic Trocar Insertion
Letter to Editor
Risk Factors Associated with Major Neonatal Birth Injuries During Caesarean Section in a Tertiary Care Hospital in Southern India
ABSTRACT Introduction: Neonatal birth injuries are commonly associated with instrumental vaginal deliveries, but have also been known to occur at uncomplicated vaginal or caesarean deliveries. Caesarean section confers s...
Natural Killer Cells - Their Role in Tumour Immunosurveillance
An important component of the innate immune system, the natural killer cells that originate from the lymphoid cell lineage, hold tremendous potential as an effective therapeutic tool to combat a variety of cancers. Their...
Pain on Injection of MCT/LCT Preparations of Propofol and Etomidate: A Double-blind Randomised Comparative Study
ABSTRACT Introduction: Propofol and etomidate are both very popular in routine practice as they have very rapid onset and offset of action when used as intravenous agents. Both these drugs have newer Medium Chain Triglyc...